Seiichiro Yamamoto

D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer

Mitsuru Sasako, Takeshi Sano, Seiichiro Yamamoto et al. · New England Journal of Medicine · 2008 · 1K citations · Full text

Medicine, Oncology, Surgery +16

Identification of Genes Upregulated in <i>ALK</i> -Positive and <i>EGFR/KRAS/ALK</i> -Negative Lung Adenocarcinomas

Hirokazu Okayama, Takashi Kohno, Yuko Ishii et al. · Cancer Research · 2011 · 881 citations · Full text

Medicine, Molecular Biology, Oncology +17

Epidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer

Toshimi Takano, Yuichiro Ohe, Hiromi Sakamoto et al. · Journal of Clinical Oncology · 2005 · 708 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Gastric Cancer Surgery: Morbidity and Mortality Results From a Prospective Randomized Controlled Trial Comparing D2 and Extended Para-Aortic Lymphadenectomy—Japan Clinical Oncology Group Study 9501

Takeshi Sano, Mitsuru Sasako, Seiichiro Yamamoto et al. · Journal of Clinical Oncology · 2004 · 678 citations · Full text

Medicine, Oncology, Surgery +17

Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial

Noriaki Ohuchi, Akihiko Suzuki, Tomotaka Sobue et al. · The Lancet · 2015 · 609 citations

Medicine, Oncology, Radiology +15